NCT Number: NCT00000369
Maintenance Therapies in Bipolar Disorders
The purpose of this study is to see if adding a regimen of individualized psychotherapy can help bipolar I patients who are on lithium.
While having a manic or depressed episode patients will be assigned randomly (like tossing a coin) to receive appropriate medication either with or without additional individual psychotherapy. If a patient responds well, he/she will again be assigned randomly to receive further preventative treatment in which medication will be managed either with continued medication clinic visits alone or with additional individual psychotherapy (the patient may not receive the same additional treatment this time). Patient response to treatment will be evaluated throughout the study. If manic/depressive symptoms return at any point during the study, the patient will be treated with appropriate medication and will continue the study.
An individual may be eligible for this study if he/she:
Has Bipolar I disorder, is experiencing a manic or depressed episode at the time of study entry, and is at least 18 years old.
Looking for future studies?
Notify MeKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
About this study
The primary goal of this investigation is to examine the additive prophylactic potential of an individual psychotherapy based on interpersonal and social rhythm principles in bipolar I patients maintained on lithium carbonate (lithium). An adaptation of maintenance interpersonal psychotherapy, this intervention takes into account the specific vulnerabilities, symptoms, and interpersonal problem areas associated with bipolar disorder.
Acutely ill patients in a manic or depressed episode are randomly assigned to either individual psychotherapy or medication clinic visits in addition to appropriate pharmacotherapy (lithium carbonate). Patients who stabilize (HRSD and Bech-Rafaelsen < 7 for four weeks) are then randomly assigned to preventative treatment with either individual psychotherapy or medication clinic visits in addition to pharmacotherapy. Thus, patients in this study receive one of four possible treatment strategies: 1) preliminary phase psychotherapy followed by preventative phase psychotherapy; 2) preliminary phase medication clinic visits followed by preventative phase psychotherapy; 3) preliminary phase psychotherapy followed by preventative phase medication clinic visits in addition to psychotherapy; or 4) preliminary phase medication clinic visits followed by preventative phase medication clinic visits in addition to psychotherapy. Those patients who experience a relapse (during the initial twelve weeks of the preventative phase) or a recurrence (after week 12 of the preventative phase) are treated with appropriate pharmacotherapy and continued in psychotherapy or medication clinic visits as dictated by their original randomization assignment. These patients are then followed for the remainder of what would have been their time in the protocol had they remained well.
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
-
Patients must have:
Acute bipolar I illness and be experiencing a manic or depressed episode at the time of study entry.
-
Required:
Current treatment with lithium carbonate.
Treatment and study plan
Lithium Carbonate
DrugSponsors and collaborators
Lead sponsor
University of Pittsburgh
Other
Registry information
Important dates
- Study start
- 1997
- Study completion
- 2002
- First posted
- Nov 3, 1999
- Registry last updated
- Jun 25, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
ACT for Syndromic and Subsyndromic Depression in Bipolar Disorder
NCT06365021
Bipolar Disorder, Bipolar and Related Disorders
São Paulo, Brazil
View Trial DetailsBezafibrateTreatment for Bipolar Depression: A Proof of Concept Study
NCT02481245
Bipolar Disorder, Bipolar and Related Disorders
Boston, Massachusetts, United States
View Trial DetailsLithium Effects on the Brain's Functional and Structural Connectome in the Treatment of Bipolar Disorder
NCT03336918
Behavior, Behavioral Symptoms
Cleveland, Ohio, United States
View Trial DetailsEffects of Theta Burst Stimulation on the Brain, Behavior, and Clinical Symptoms in Adults With Bipolar Disorder
NCT04696471
Bipolar Disorder, Bipolar and Related Disorders
Pittsburgh, Pennsylvania, United States
View Trial Details